There have been numerous studies that questioned the safety of acid suppression, particularly from PPI therapy, also in the hospital setting.
To some degree, those concerns may be applicable to the critically ill population. Studies suggest
that PPI therapy may be associated with increased risk of hospital acquired pneumonia